Akero Therapeutics, Inc.

CHARLES SCHWAB INVESTMENT MANAGEMENT INC AKRO

Report date

9/30/2025

Quarter

2025 Q3

Filed

11/10/2025

Shares

612,126

Value ($000)

29,064

Weight

0.0%

2019 Q4 - 2025 Q3 (24 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2025 Q3	11/10/2025	29,064	0.0%	612,126	9/30/2025
2025 Q2	8/12/2025	32,777	0.0%	614,266	6/30/2025
2025 Q1	9/15/2025	23,570	0.0%	582,254	3/31/2025
2024 Q4	2/6/2025	15,042	0.0%	540,692	12/31/2024
2024 Q3	11/12/2024	15,280	0.0%	532,596	9/30/2024
2024 Q2	8/12/2024	13,017	0.0%	554,865	6/30/2024
2024 Q1	5/9/2024	13,092	0.0%	518,286	3/31/2024
2023 Q4	2/6/2024	9,936	0.0%	425,545	12/31/2023
2023 Q3	11/8/2023	21,215	0.0%	419,430	9/30/2023
2023 Q2	8/10/2023	13,758	0.0%	294,662	6/30/2023
2023 Q1	5/12/2023	9,119	0.0%	238,347	3/31/2023
2022 Q4	2/13/2023	12,966	0.0%	236,597	12/31/2022
2022 Q3	11/14/2022	7,254	0.0%	213,019	9/30/2022
2022 Q2	8/15/2022	1,558	0.0%	164,823	6/30/2022
2022 Q1	5/13/2022	2,463	0.0%	173,546	3/31/2022
2021 Q4	2/11/2022	3,686	0.0%	174,252	12/31/2021
2021 Q3	11/16/2021	3,696	0.0%	165,353	9/30/2021
2021 Q2	8/16/2021	3,449	0.0%	138,993	6/30/2021
2021 Q1	5/17/2021	3,224	0.0%	111,111	3/31/2021
2020 Q4	2/16/2021	2,785	0.0%	107,932	12/31/2020
2020 Q3	11/13/2020	3,320	0.0%	107,813	9/30/2020
2020 Q2	8/20/2020	1,270	0.0%	50,945	6/30/2020
2020 Q1	5/15/2020	940	0.0%	44,326	3/31/2020
2019 Q4	2/7/2020	804	0.0%	36,224	12/31/2019